Zhengqing Group solemnly convened its 2026 Annual Science and Technology Innovation Conference.

From January 25 to 27, Zhengqing Group grandly convened its 2026 Annual Science and Technology Innovation Conference in Huaihua. More than 70 key scientific and technological personnel and experts from the Group attended the meeting, which was jointly presided over by Group Chairman and President Wu Feichi, Vice Chairman Huang Yuming, Supervisory Board Chairman and Trade Union President Xiang Weiguo, Rotating President Long Xianjun, and other senior leaders of the Group.

The meeting invited the Municipal Science and Technology Bureau. Fourth-Level Researcher Jiang Chengqi, Zhu Sheng, Deputy Director of the High-tech Zone Management Committee, and Zhengqing Group Liu Liang Professor Li Yanping, Deputy Director of the Academician and Expert Workstation; Professor Qiu Saihong, Chief Pharmacology Expert at the Liu Liang Academician and Expert Workstation of Zhengqing Group; Professor Yang Hua, Dean of the College of Biological Science and Technology at Hunan Agricultural University and doctoral supervisor; Professor Liu Jianxin, Dean of the School of Pharmacy at Hunan University of Chinese Medicine and master’s supervisor; Xu Wen, Assistant Researcher at the Huaihua Municipal Bureau of Agriculture and Rural Affairs; Associate Professor Xiao Yunhua, Lecturer at the College of Biological Science and Technology of Hunan Agricultural University and master’s supervisor; Zhang Shaonian, Head of the Zhide Key Projects Department and a Chinese patent attorney, along with other leading experts, attended the event.

PART.01-02

Thematic Reports, Results Exchange, and Research Planning

Exchange of Typical Achievements

▲Dean Yang Hua released the monograph “Resources and Utilization of Qingfengteng”

Annual Research Summary Plan

Exchange of Remarks

PART.3

Award Ceremony

During the third phase of the meeting, chaired by Xiang Weiguo, Chairman of the Group’s Supervisory Board and Chairman of the Trade Union, Xiang Weiguo first announced the 2025 research project and achievement award scheme, with a total prize pool of nearly RMB 600,000.

In 2025, thanks to the concerted efforts of all scientific and technical personnel within the Group’s research system, the provincial major science and technology project—the Qingfengteng full‑industry‑chain initiative—successfully passed acceptance; the low‑frequency ultrasonic drug‑delivery device received market approval; Zhengqing Fengtongning sustained‑release tablets were launched in Macao, with European registration work initiated concurrently last year; 46 research projects were fully underway, and a total of 13 projects completed their final evaluations and passed acceptance throughout the year; three patents were granted, eight patent applications were filed (and accepted), and five software copyrights were duly registered.

Zhu Sheng, Deputy Director of the High-tech Zone Management Committee; Jiang Chengqi, Fourth-level Researcher at the Huaihua Municipal Science and Technology Bureau; and Wu Feichi, Chairman and President of the Group; Huang Yuming, Vice Chairman; Long Xianjun, Rotating President; Yang Xiuchun and Qiu Qunying, Assistant Presidents; Peng Yilin, Chief Financial Officer; and Yin Songmao, Special Assistant to the President, presented awards to the winners in succession.

PART.4

Leadership Address

The fourth session of the meeting was chaired by Huang Yuming, Vice Chairman of the Group. He once again extended his congratulations to the researchers who received awards and encouraged them to deepen their commitment to TCM research, persist in pioneering breakthroughs, and strive to achieve new heights in scientific innovation.

Experts unanimously agreed that technological innovation is the solid cornerstone of corporate development, laying a robust technological foundation for Zhengqing Group’s high-quality growth. The outstanding performance of Zhengqing’s research team at this Technology Innovation Conference fully underscores the company’s deep-rooted technological heritage and its formidable R&D capabilities.

In her address, Zhu Sheng stated that by 2025, Zhengqing Group had delivered an impressive performance, particularly in the realm of scientific research and innovation, where it has consistently invested effort and achieved substantial results—efforts that deserve recognition. She expressed the hope that Zhengqing Group will continue to serve as a model and leader in science and technology, actively sharing its valuable experience in building a robust R&D workforce with other enterprises within the park, thereby elevating the park’s overall level of technological innovation to a new height. At the same time, she pledged that, as a professional in science and technology management, she would excel in providing supportive services and work hand-in-hand with all stakeholders to contribute to the high-quality development of science and technology in Huaihua.

In his guiding remarks, Jiang Chengqi highly commended the achievements of Zhengqing Group in 2025, as well as the dedication and professional expertise of the participating experts and research teams. He expressed the hope that Zhengqing would take on a proactive role in driving the high-quality, large-scale development of the traditional Chinese medicine industry in Huaihua. The science and technology authorities will pool resources to ensure the smooth operation of the Provincial Innovation Center for Process Technology in Modern Traditional Chinese Medicine, strive to elevate it to national status, provide robust support services, foster corporate innovation, secure additional resources, and work together to promote the prosperity of the regional industry.